Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results

Go back to Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results
GALMED PHARMACEUTIC (NASDAQ: GLMD) Delayed: 0.55 -0.01 (1.79%)
Previous Close $0.56    52 Week High $9.70 
Open $0.53    52 Week Low $2.78 
Day High $0.56    P/E N/A 
Day Low $0.53    EPS $0.00 
Volume 12,993